Replies to post #73398 on Biotech Values

[DewDiligence]

Re: Copaxone, Tysabri market shares

I have neither the time nor inclination to check worldwide prices of each drug. They may vary somewhat in different locales.

Copaxone prices vary by geography to a larger degree than most expensive drugs. Moreover, your spot check of the retail Copaxone price at one US hospital and pharmacy is not a good indication of Teva’s Copaxone ASP even in the US; there are various middlemen between Teva and the entities who quoted your prices, which is the subject of a prior thread on this board (#msg-35353328). In short, your claims about Copaxone pricing strike me as shooting from the hip.

Which brings us back to where this thread started. I think it’s patently clear from the most recent numbers that Copaxone is indeed cleaning Tysabri’s clock, painful as this may be for you to accept. Regards, Dew